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Background: Manually annotated corpora are critical for the training and evaluation of automated methods to
identify concepts in biomedical text.
Results: This paper presents the concept annotations of the Colorado Richly Annotated Full-Text (CRAFT) Corpus, a
collection of 97 full-length, open-access biomedical journal articles that have been annotated both semantically and
syntactically to serve as a research resource for the biomedical natural-language-processing (NLP) community.
CRAFT identifies all mentions of nearly all concepts from nine prominent biomedical ontologies and terminologies:
the Cell Type Ontology, the Chemical Entities of Biological Interest ontology, the NCBI Taxonomy, the Protein
Ontology, the Sequence Ontology, the entries of the Entrez Gene database, and the three subontologies of the
Gene Ontology. The first public release includes the annotations for 67 of the 97 articles, reserving two sets of 15
articles for future text-mining competitions (after which these too will be released). Concept annotations were
created based on a single set of guidelines, which has enabled us to achieve consistently high interannotator
agreement.
Conclusions: As the initial 67-article release contains more than 560,000 tokens (and the full set more than 790,000
tokens), our corpus is among the largest gold-standard annotated biomedical corpora. Unlike most others, the
journal articles that comprise the corpus are drawn from diverse biomedical disciplines and are marked up in their
entirety. Additionally, with a concept-annotation count of nearly 100,000 in the 67-article subset (and more than
140,000 in the full collection), the scale of conceptual markup is also among the largest of comparable corpora. The
concept annotations of the CRAFT Corpus have the potential to significantly advance biomedical text mining by
providing a high-quality gold standard for NLP systems. The corpus, annotation guidelines, and other associated
resources are freely available at http://bionlp-corpora.sourceforge.net/CRAFT/index.shtml.Background
With the digitalization of much of the biomedical litera-
ture, automated processing of journal publications has
become increasingly important in biomedical research.
Biomedical researchers struggle to keep abreast of the
exponentially growing literature, due to not only its
sheer scale but also to the expanding range of disciplines
and journals relevant to a typical research question. Bio-
medical publications, like most texts, are fraught with
synonymy, polysemy, ambiguity, and complexity. Trans-
formation of these texts into formal representations of
the contained knowledge makes possible the application
of sophisticated computational methods that assist* Correspondence: mike.bada@ucdenver.edu
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reproduction in any medium, provided the orresearchers and advance science. Substantial progress in
biomedical natural-language processing (NLP), particu-
larly in the tasks of information retrieval, concept recogni-
tion, and information extraction [1-5] raises the possibility
of creating formal representations for the entire biomed-
ical literature.
Development of formal ontologies for the representation
of domain-specific knowledge has also made substantial
progress [6]. Among the most ambitious of these efforts
are the Open Biomedical Ontologies (OBOs), a set of
ontologies whose domains include anatomy, biological
processes and functions, cells and cellular components,
chemicals, phenotypes and diseases, and experiments and
procedures. These ontologies are largely constructed in a
community-driven approach, and their developers commit
to a common set of attributes including openness, shared
syntax, clear versioning, demarcated content, and cleard. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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medical data sets have been annotated with ontological
terms, and these annotations are widely used as the basis
for high-throughput data analysis. In particular, calcula-
tions of enrichment of Gene Ontology (GO) terms in sets
of differentially expressed genes are widely used [8-10],
and more sophisticated uses of formal knowledge repre-
sentations in data analysis are beginning to be published
(e.g., [11]).
Manually annotated, or “gold-standard”, corpora are
increasingly important for the development of sophisti-
cated NLP systems, both as training data and for evalu-
ative purposes. Use of manually annotated biomedical
corpora in NLP research has consistently led to improved
results. In a study by Tomanek et al., the accuracy of toke-
nization of a test set of biomedical text increased from
71.5% when their tool was trained on a corpus that was
tokenized using newspaper language patterns to 95.9%
when their tool was trained on a corpus whose tokeniza-
tion was biomedically motivated [12]. Kulick et al. showed
that accuracy of part-of-speech annotation of biomedical
text increased from 88.53% to 97.33% on test abstracts
when their tagger was retrained after the training corpus
was manually checked and corrected [13], and Coden
et al. found that adding a small biomedical annotated cor-
pus to a large general-English one increased accuracy of
part-of-speech tagging of biomedical text from 87% to
92% [14]. Lease and Charniak demonstrated large reduc-
tions in unknown word rates and large increases in accur-
acy of part-of-speech tagging and parsing when their
systems were trained with a biomedical corpus as com-
pared to only general-English and/or business texts [15].
It was shown by Roberts et al. that the best results in rec-
ognition of clinical concepts (e.g., conditions, drugs,
devices, interventions) in biomedical text, ranging from
10% below to 11% above the interannotator-agreement
scores for the gold-standard test set, were obtained with
the inclusion of statistical models trained on a manually
annotated corpus as compared to dictionary-based con-
cept recognition solely [16]. Craven and Kumlein found
generally higher levels of precision of extracted biomedical
assertions (e.g., protein-disease associations and subcellu-
lar, cell-type, and tissue localizations of proteins) for
Naïve-Bayes-model-based systems trained on a corpus of
abstracts in which such assertions were manually anno-
tated, as compared to a basic sentence-cooccurrence-
based method [17].
In recognition of the importance of such corpora, the
Colorado Richly Annotated Full-Text (CRAFT) Corpus,
a collection of 97 full-length, open-access biomedical
journal articles selected from the regular annotation
stream of a major bioinformatics resource, has been
manually annotated to indicate references to concepts
from multiple ontologies and terminologies. Specifically,it contains annotations indicating all mentions in each
full-length article of the concepts from nine prominent
ontologies and terminologies: the Cell Type Ontology
(CL, representing cells) [18,19], the Chemical Entities of
Biological Interest ontology (ChEBI, representing chemi-
cals, chemical groups, atoms, subatomic particles, and
biochemical roles and applications) [20], the NCBI Tax-
onomy (NCBITaxon, representing biological taxa) [21],
the Protein Ontology (PRO, representing proteins and
protein complexes), the Sequence Ontology (SO, repre-
senting biomacromolecular sequences and their asso-
ciated attributes and operations) [22,23], the entries of
the Entrez Gene database (EG, representing genes and
other DNA sequences at the species level) [24], and the
three subontologies of the GO, i.e., those representing
biological processes (BP), molecular functions (MF), and
cellular components (CC) [25,26].
The first public release of the CRAFT Corpus includes
the annotations for 67 of the 97 articles, reserving two
sets of 15 articles for future text-mining competitions
(after which these too will be released)., This corpus is
among the largest gold-standard annotated biomedical
corpora, and unlike most others, the journal articles that
comprise the documents of the corpus are marked up in
their entirety and range over a wide range of disciplines,
including genetics, biochemistry and molecular biology,
cell biology, developmental biology, and even computa-
tional biology. The scale of conceptual markup is also
among the largest of comparable corpora. While most
other annotated corpora use small annotation schemas,
typically comprised of a few to several dozen classes, all
of the conceptual markup in the CRAFT Corpus relies
on large ontologies and terminologies nearly in their en-
tirety, creating an unprecedentedly rich semantic re-
source. Since we have been guided by marking up
textual mentions with their directly corresponding onto-
logical and terminological concepts, these mentions are
marked up without loss of knowledge.. All of the con-
cept annotations of all terminologies used were created
using a single set of guidelines, making clear which
spans of text are to be marked up and what the span
boundaries should be, which has resulted in high inter-
annotator agreement. Along with the syntactic [27] and
coreferential [28] annotations that have been created for
the same set of journal articles, the concept annotations
of the CRAFT Corpus have the potential to significantly
advance biomedical text mining by providing a high-
quality gold standard for bioNLP systems.
Following this brief introduction, we will present the
salient statistics for the conceptual markup of the corpus
in the form of counts of concept annotations and of
unique annotated concepts for each of the vocabularies
used, as well as the formats in which this markup is
being released. This is followed by an in-depth comparison
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of other publicly available manually annotated gold-
standard biomedical corpora as well as several other rele-
vant projects, along with a discussion of the aspects of our
concept annotations that we claim are prominent factors in
their being a significant contribution to the bioNLP com-
munity. Ongoing and future work is then briefly described,
followed by our conclusions. The primary text of our paper
ends with methodology with regard to corpus assembly, ter-
minology selection, creation of annotation guidelines, and
creation of the conceptual markup. Finally, as supplemen-
tary material, we provide an extensive presentation of our
concept-annotation guidelines and a spreadsheet of our
interannotator-agreement statistics in detail.
Results
The articles in the CRAFT Corpus have been completely
marked up with the full sets of conceptsa (minus a small
number of terms) of nine biomedical ontologies and ter-
minologies. Here we present annotation-count and
interannotator-agreement statistics for the conceptual
annotation. In a companion paper [27] we present the
syntactic annotation (i.e., of sentences, tokens and parse
trees) of the CRAFT Corpus and studies in which it was
used to train high-performing models, providing indirect
evidence of its high quality.
Concept annotation statistics
Table 1 presents statistics for the counts of concept anno-
tations in total and also for each ontology and terminology
in the 67 articles constituting the initial public release of
the CRAFT Corpus. These data show that the mentions of
the concepts of these ontologies and terminologies are
abundant: There is a total of 99,907 concept annotations
in these articles, ranging from 4,062 annotations of GO
MF concepts to 22,090 annotations of SO concepts. Fur-
thermore, as the initial public release consists of approxi-
mately two thirds of the articles in the entire corpus, the
annotations in the entire corpus total more than 140,000
(not shown). There is an average of 1,491 annotations of
the concepts from all of these terminologies per article,
ranging from an average of 61 mentions of GO MF con-
cepts per article to 330 mentions of SO concepts per art-
icle. However, as the values of the median counts of
annotations per article are lower than their corresponding
averages per article, and in most cases substantially so,
these averages are skewed upward by smaller numbers of
articles with very high annotation counts. The last two
columns of Table 1, which present minimum and max-
imum counts per article, indicate that there is indeed a
very wide range of annotations per article across the arti-
cles for all of these terminologies.
Table 2 presents statistics for the counts of unique
concepts mentioned in these articles, both totaled andfor each ontology and terminology in these 67 articles.
These data show that these concept mentions are also
diverse: There is a total of 4,319 unique concepts from
these ontologies and terminologies mentioned in these
articles, ranging from 149 unique NCBI Taxonomy con-
cepts to 1,024 unique Entrez Gene concepts. There is an
average of 192 unique concepts of these ontologies and
terminologies mentioned per article, ranging from 7
unique CL concepts per article to 41 unique SO con-
cepts per article. As with the annotation counts, there is
a wide range of unique concepts mentioned per article
across the articles for all of these terminologies, as indi-
cated by their minimum and maximum counts of unique
concepts mentioned per article. However, the median
counts of unique concepts mentioned per article overall
are very close to their corresponding average values, in-
dicating that the averages are not skewed much by out-
lier values.
Interannotator-agreement statistics
Figures 1 and 2 illustrate that the use of our concept an-
notation guidelines (which we present in detail as sup-
plementary material) has enabled consistently high
interannotator agreement after a short initial period of
working with a newly encountered ontology. Our anno-
tators, who are domain experts, not knowledge engi-
neers (nor linguists), were able to quickly reach and with
occasional exception remain at a 90 +% IAA level for all
of the terminological annotation passes except for the
challenging GO BP & MF passb. Oscillations in these fig-
ures are partly explained by the fact that an annotator
may make the same type of error many times in a given
article, which can strongly affect IAA statistics. For ex-
ample, a given article often has many mentions of some
concept, and two annotators might consistently annotate
these mentions differently, leading to a considerable
drop in IAA. For example, the large drop seen in the
eighth data point for the CL project is almost wholly at-
tributable to the consistently discrepant annotation of
the several dozen mentions of polymorphonuclear leu-
kocytes/PMNs in one article. (One annotator marked up
these mentions using CL:granulocyte (CL:0000094) and
the other with CL:mature neutrophil (CL:0000096), one
of its subclasses.) In addition to Figures 1 and 2 within
this paper, we have included a spreadsheet of the precise
IAA statistics for all of the annotation passes as supple-
mentary material (Additional file 1: Doc1).
This degree of IAA is impressive, given that the anno-
tation schemas (i.e., the contents of the target ontolo-
gies) are very large (ranging from ~800 to hundreds of
thousands of concepts) as compared to the typical text-
ual annotation project, which uses a schema of no more
than dozens of classes. Furthermore, a very strict stand-
ard of matching was used in the calculation of these











ChEBI 8,137 121 94 11 486
CL 5,760 86 58 0 435
Entrez Gene 12,277 183 155 3 543
GO BPa 16,184 241 194 14 738
GO CC 8,354/4,707b 125/70 97/51 9/0 499/322
GO MF 4,062 61 42 2 403
NCBITaxonc 7,449 111 91 12 378
PRO 15,594 233 207 4 704
SOd 22,090 330 328 72 935
all 99,907 1,491e
aWe are still in the process of reviewing and editing the GO BP & MF annotations for the official 1.0 version release; therefore, the statistics for these will likely
change. We will update annotation statistics on the project Web site as needed.
bWe have calculated statistics for the GO CC project both with and without the annotations of cell (GO:0005623), as these account for over half of the annotations
of this project. In addition to skewing these statistics, since this is such a trivial concept that is also being annotated in the CL project, users may wish to exclude
these annotations for training and evaluation of systems.
cIn addition to the hundreds of thousands of organism entries, the NCBI Taxonomy also has a small taxonomy of types of biological taxa (e.g., phylum, genus,
subgenus). For the NCBI Taxonomy pass, there are also a small number of annotations of the mentions of these taxonomic concepts in the articles; however, we
have excluded these in these statistics.
dFor the SO statistics, the independent_continuant annotations (as described in the Methodology) were excluded from the analysis.
eThe averages of the total number of annotations per article and of unique concepts per article were calculated simply by adding up the averages for each
terminological annotation pass.
Counts of annotations and of average, median, minimum, and maximum counts of annotations per article for the 67 articles constituting the initial public release
of the CRAFT Corpus.
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ered a match only if they used the exact same class/term
and specified the exact same text span. For many of the
mismatches (which result in the lowering of IAA), the
given pair of annotations used closely related classes
(e.g., a class and its subclass) and/or had only slightly
different text spans; thus, even a slight relaxing of the
matching criteria would result in even higher IAA
figures.
As presented in the Methodology section, most of
these data points are single-blind statistics, in which the
lead semantic annotator inspected the markup of theTable 2 Counts of unique annotated concepts






ChEBI 553 32 2
CL 155 7
Entrez Gene 1,024 18 1
GO BP 758 40 4
GO CC 213/212 12/11 1
GO MF 318 13 1
NCBITaxon 149 11 1
PRO 889 18 1
SO 260 41 4
all 4,319 192
Counts of unique mentioned concepts and of average, median, minimum, and max
constituting the initial public release of the CRAFT Corpus.annotators, edited (by adding, deleting, or modifying)
markup with which he disagreed, and calculated the
agreement between the original markup and the edited
version. We have also annotated a small number of arti-
cles in a double-blind fashion, including the last three
articles of the corpus (corresponding to the last three
data points of Figure 1) annotated with the BP and MF
branches of the GO, which resulted in IAAs of 83.4%,
83.9%, and 78.0%, in concordance with previous data
points, as can be seen in this figure. These (albeit lim-
ited) data suggest that the single-blind IAAs are unlikely















imum counts of unique mentioned concepts per article for the 67 articles
Figure 1 IAA statistics for ChEBI and GO BP/MF, and GO CC markup. Plot of IAA versus number of training sessions/meetings (approximately
weekly) for annotation of the corpus with the ChEBI ontology, GO BP & MF, and CC. IAA has been calculated as F-score, which is the harmonic
mean of precision and recall.
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annotation for the majority of the articles of the corpus
is simply a lack of resources; as it is, the creation of this
semantic markup has entailed tens of thousands of
person-hours over more than four years of effort. Add-
itionally, for the creation of a gold-standard annotated
corpus, we have found it crucial for a knowledge engin-
eer to thoroughly review the markup using the concepts
of these ontologies. It is necessary not only to have a
broad familiarity with the ontologies being used but also
to have a deeper understanding of their representational
subtleties and assumptions that domain experts may
very well never even consider much less make sense of
by themselves. For example, the ChEBI ontology con-
tains a subgraph for amino acids as discrete molecules
(e.g., CHEBI:serine), another for those as amino-acidFigure 2 IAA statistics for CL, NCBITaxon, and SO markup. Plot
of IAA versus number of training sessions/meetings (approximately
weekly) for annotation of the corpus with the SO, CL, and NCBI
Taxonomy. IAA has been calculated as F-score, which is the
harmonic mean of precision and recall.residues within peptide chains (e.g., CHEBI:serine resi-
due), and another for the molecules' derived substituent
groups (e.g., CHEBI:seryl group), and using these cor-
rectly and consistently at first may not be at all obvious;
indeed, the annotator using ChEBI to mark up the arti-
cles of the CRAFT Corpus incorrectly used the molecu-
lar terms for many of the residue mentions (e.g., as in
"serine 132") before the semantic lead observed this and
provided guidance. Additionally, many ontologies have
their own idiosyncrasies and often even ambiguous or
dubious modeling, and expertise in knowledge engineer-
ing is very valuable in deciding how to deal with these
representational issues with regard to their use in text
annotation [31,32]. The CRAFT Corpus was constructed
on the assumption that a consensus set of annotations
resulting from single-blind evaluation by a competent
knowledge engineer of ontology-based markup created
by a domain expert would result in a higher-quality
annotated corpus than a consensus set of annotations
resulting from double-blind annotation by multiple do-
main experts. The soundness of this approach is sup-
ported by recent studies by Dligach et al. that have
shown that single-annotating more data as opposed to
double annotation is more cost-effective in improving
system performance [33] and that double annotation can
be greatly reduced without loss of system performance
[34].
Distribution formats
The CRAFT Corpus concept annotations have been
released in multiple formats to promote ease of use and
community uptake. The release includes both the full-
text documents and sets of conceptual and syntactic an-
notation artifacts accompanying each document. All
CRAFT Corpus documents are drawn from the PubMed
Central (PMC) Open Access subset [35], licensed to
allow redistribution. The CRAFT Corpus release includes
two versions of each document: an XML version provided
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derived from the XML, the latter of which was used by
the annotators to generate concept markup. The character
offsets referenced by the annotations are therefore relative
to the plain-text documents and not the original XML; in-
clusion of the XML format in the distribution is for prov-
enance only.
We have provided these concept annotations in both
the XML-based GENIA Project Markup Language
(GPML) [36], and in the W3C-standard Resource De-
scription Framework (RDF). CRAFT Corpus annotations
in GPML will allow quick uptake by users with software
based on the well-known GENIA corpus, and the ver-
sion in RDF will open the corpus up to the Semantic
Web community. It is important to note that because
discontinuous annotations (i.e., annotations composed of
two or more disconnected text spans) cannot be unam-
biguously represented in GPML, we have excluded all
such annotations from this version; thus, the set of con-
cept annotations in the GPML version of the CRAFT
Corpus is be regarded as incomplete. An XML-based
format produced by the Knowtator annotation tool [37],
which is also widely used in the text annotation commu-
nity, is provided as well.
To facilitate use in NLP generally, we have also
released CRAFT tools for the Unstructured Information
Management Architecture (UIMA) [38], a popular open-
source middleware layer for text processing. The CRAFT
Corpus documents and annotations have been bundled
as serialized UIMA Common Analysis Structures
(CASes), and we provide a UIMA collection-reader com-
ponent for them.
For browsing and exploratory purposes, we plan to in-
tegrate the CRAFT Corpus with two online resources:
U-Compare [39] and Massachusetts General Hospital’s
Document Metadata Organizer (DOMEO) application,
formerly called the SWAN annotation tool [40]. U-
Compare is a Web-based NLP system relying on UIMA
that allows users to set up and run text-processing pipe-
lines using a variety of tools over a variety of corpora.
DOMEO is a Web-enabled annotation tool designed for
markup of scientific articles with ontology terms and will
allow an easy introduction to the corpus by facilitating
browsing of its data. Furthermore, we have already inte-
grated the CRAFT Corpus with BRAT (brat rapid anno-
tation tool) [41], with which our concept annotations can
be browsed online at http://compbio.ucdenver.edu/Craft.
Note, however, that BRAT cannot render discontinuous
annotations (i.e., annotations consisting of two or more
disconnected text spans) properly. For each discontinuous
annotation, the shortest span of text encompassing all
of the text spans is instead highlighted. However, in
BRAT, if the cursor hovers over an icon indicating an an-
notation, a window pops up specifying the annotated text,the concept with which this text is annotated, and
the terminology of which this concept is a member;
for discontinuous annotations, the correct discon-
nected spans of text are displayed as the last line in
this popup window.
The corpus, annotation guidelines, and other associated
resources are freely available at http://bionlp-corpora.
sourceforge.net/CRAFT/index.shtml.
Discussion
CRAFT can be compared to a number of previously
released corpora. We focus primarily on biomedical
corpora, as these are obviously most directly related:
ABGene [42], BioInfer [43], the CLEF Corpus [44], the
FetchProt Corpus [45], the Fourth i2b2/VA Challenge
corpus [46], GENETAG [47], GENIA [48,49], GREC
[50], the ITI TXM PPI and TE corpora [51], MedPost
[52], the PennBioIE Oncology and CYP v1.0 corpora
[13], and the Yapex corpus [53]. Though it bills itself as
a “silver standard”, due to its vast scale we also compare
CRAFT to the output of the Collaborative Annotation of
a Large Biomedical Corpus (CALBC), an effort at con-
structing a very large biomedical corpus through
“harmonization” of the automatically generated annota-
tions of five systems [54]. Finally, though it focuses on
newswire articles, we also compare our corpus to Onto-
Notes Release 2.0 here, as it is analogously a large-scale
manually created corpus project with multiple types of
semantic and syntactic annotation [55,56]. Table 1 sum-
marizes some criteria by which we compare CRAFT to
other corpora.
Comparison of corpora in terms of total numbers of
words/tokens is summarized in Table 3. The full corpus
contains ~790,000 tokens, and the initial release con-
tains more than 560,000; they are larger than nearly all
gold-standard annotated corpora (for which we could
find published numbers), including GENETAG, Onto-
Notes, GENIA, the PennBioIE Oncology and CYP Cor-
pora, the MedPost Corpus, and BioInfer. The only
corpora larger than ours by this criterion is the silver-
standard CALBC corpus, with ~16,000,000 tokens, and
the gold-standard ITI TXM PPI and TE Corpora, with
~2,000,000 and ~1,900,000 tokens, respectively; however,
the counts of the ITI TXM corpora include all versions
of the subset of documents that were multiply annotated
(independently, for IAA calculation), and, as discussed
later, not all sections of the component documents of
these corpora were annotated.
Corpora can also be compared on the size of the docu-
ments annotated, also summarized in Table 3. Most of
the corpora surveyed here are composed of relatively
short documents. Among the shortest are those docu-
ments that are individual sentences, which compose the
GENETAG, the ABGene Corpus, and BioInfer corpora.
Table 3 Concept annotation attributes of corpora
corpus/corpora total # words/tokens # & type of
documents




~790,000/~560,000 97/67 articles sources of MGI
annotations of mouse
genes/gene products
Open Biomedical Ontologies (CL,
ChEBI, SO, PRO, GO BP/CC/MF,
NCBITaxon), Entrez Gene
~140,000/~100,000
ABGene 4,265 sentences n/a ~8,200
BioInfer ~34,000/~30,000f 1,100 sentences protein-protein
interactions




CALBC corpus ~16,000,000 150,000 abstracts immunology UniProt, NCBITaxon, UMLSh ~2,700,000
CLEF Corpus variousi clinical/cancer data 6 concept types
FetchProt Corpus 200 articles protein tyrosine kinase
activity





clinical data 3 concept types ~2,000
GENETAG ~548,000 20,000 sentences n/a ~25,000 genes/proteins,
~19,000 alternative lexical
forms
GENIA 3.0 ~440,000 2,000 abstracts human blood-cell
transcription factors
35 entity classes, 34 process classes ~93,000 entities, ~36,000
events








9/13 concept types, Entrez Gene,
RefSeqj, ChEBI, MeSH, NCBITaxonk
~160,000/~164,000
MedPost ~156,000
OntoNotes 2.0 ~500,000 1,000 newswire
documents














Yapex Corpus 200 abstracts protein-protein
interactions
n/a ~3,700
fBioInfer has ~34,000 tokens total, and ~30,000 excluding punctuation.
gBioInfer has ~6,300 named-entity annotations and ~2,700 annotations of what are termed relationships but that might more properly be conceptualized as
process or state classes and thus are included here, totaling ~9,000 concept annotations.
hIn the CALBC corpus, NCBI Taxonomy and UMLS concepts were respectively used to mark up species and disease mentions.
1The CLEF Corpus is composed of many types of medical documents: 2 entire patient records (themselves composed of 9 narratives, 1 imaging report, 7
histopathology reports, and associated data) and 50 each of clinical narratives, histopathology reports, and imaging reports.
jThe annotators of the ITI TXM Corpora attempted to assign Entrez Gene IDs to gene annotations and RefSeq IDs to annotations of proteins, mRNAs, and cDNAs
(although it is admitted that this assignment was very time-consuming and thus was not performed on the training subset of the PPI Corpus).
kThe annotators of the ITI TXM Corpora used ChEBI, MeSH, and NCBI Taxonomy concepts for drug, tissue, and sequence mentions.
lIn OntoNotes, the 700 most frequent polysemous verbs and 1,100 most frequent polysemous nouns have been annotated with the appropriate senses of
WordNet 2.0, so the size of the schema (i.e., the total number of senses of these 1,800 words) likely numbers in the thousands; however, they note that this is
different from their ontological annotation, for which only approximately 50 concept types are being used to subsume the annotated word senses.
mIn addition to ~58,000 annotated verbs, OntoNotes has an unstated but presumably large count of annotated nouns.
A summary of counts of words/tokens, of counts and types of component documents, of domains, and of counts of concept annotations for the CRAFT Corpus
and related corpora.
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of several sentences to a paragraph, typically publication
abstracts, e.g., the CALBC corpus, GENIA, the Penn-
BioIE Oncology and CYP Corpora, GREC, and the Yapex
Corpus, as well as those composed of discharge sum-
maries, e.g., the Fourth i2b2/VA Challenge Corpus. The
CLEF Corpus is composed of a number of different
types of moderately sized medical documents, and the
OntoNotes corpus contains 1,000 multiparagraph news-
wire documents. The longest documents of these sur-
veyed corpora are full-length biomedical articles, e.g., theITI TXM PPI and TE Corpora, the FetchProt Corpus,
and the CRAFT Corpus. In the biomedical domain, hav-
ing access to full-length articles is increasingly seen as
important for concept-identification and information-
extraction efforts [57-60].
Another point of comparison of annotated corpora is
in terms of their respective domain(s), also summarized
in Table 3. The corpora surveyed are within the biomed-
ical domain, with the exception of OntoNotes, which
covers English and Chinese newswire text. The CLEF
Corpus and the i2b2/VA Challenge Corpus contain
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issues of patient confidentiality of medical records. The
remainder of the corpora discussed here are composed
of sentences, abstracts, or full-length articles culled from
MEDLINE. However, most of these are further narrowed
to one or several relatively specific biomedical domains.
In addition to requiring open licensing, the articles of
the CRAFT Corpus were selected for their being eviden-
tial sources for one or more GO and/or MP annotations
of mouse genes or gene products. Apart from focusing
on the laboratory mouse (though not exclusively, as evi-
denced by the unique-concept statistics for the NCBI
Taxonomy annotations, as seen in Table 2), the articles
have no predefined constraints within the biomedical
domain, and the corpus includes articles ranging over
the disciplines of genetics, biochemistry and molecular
biology, cell biology, developmental biology, and even
computational biology. While our corpus does not in-
clude examples of articles that do not support GO and/
or MP annotations of mouse genes/gene products, e.g.,
clinical studies, it otherwise reflects a broad overview of
the biomedical literature. Compared to other publicly
available corpora, CRAFT is a less biased sample of the
biomedical literature, and it is reasonable to expect that
training and testing NLP systems on CRAFT is more
likely to produce generalizable results than those trained
on narrower domains. At the same time, since our cor-
pus primarily concentrates on mouse biology, we expect
our corpus to exhibit some bias toward mammalian
systems.
One of the most important aspects of the semantic
markup of corpora is the total number of concept anno-
tations, for which we have provided statistics in Table 3.
The full corpus contains over 140,000 annotations to
terms from ontologies and other controlled terminolo-
gies; the initial release contains nearly 100,000 such
annotations. This is among the most extensive concept
markup of the corpora discussed here for which we have
been able to find such counts, including the ITI TXM
PPI and TE corpora, GENIA, and OntoNotes, and it is
considerably larger than that of most corresponding pre-
viously released corpora, including GENETAG, BioInfer,
the ABGene corpus, GREC, the CLEF Corpus, the Yapex
corpus, and the FetchProt Corpus. The only corpus with
amounts of concept markup considerably larger than
ours (and for which we have been able to find such data)
is the silver-standard CALBC corpus.
A significant difference between the CRAFT Corpus
and many other corpora is in the size and richness of
the annotation schemas used, i.e., the concepts that are
targeted for tagging in the text, also summarized in
Table 3. Some corpora, including the ITI TXM Corpora,
the FetchProt Corpus, and the CALBC corpus, used
large biomedical databases for portions of their entityannotation, though most were done in a limited fashion.;
furthermore, though such databases represent large
numbers of biological entities, the records are flat sets of
entities rather than concepts that themselves are embed-
ded in a rich semantic structure. There has been a small
amount of corpus annotation with large vocabularies
with at least hierarchical structure, among these the ITI
TXM Corpora and the CALBC corpus, though these are
limited in various ways as well. OntoNotes, the GREC,
and BioInfer use custom-made schemas whose sizes
number in the hundreds, while most annotated corpora
rely on very small concept schemas. In the CRAFT Cor-
pus, all concept annotation relies on extensive schemas;
apart from drawing from the ~7,200,000 records of the
Entrez Gene database, these schemas draw from ontolo-
gies in the Open Biomedical Ontologies library, ranging
from the ~800 classes of the Cell Type Ontology to the
~410,000 concepts of the NCBI Taxonomy. The initial
67-article release of the CRAFT Corpus contains over
4,300 distinct concepts from these terminologies. Fur-
thermore, the annotation of relationships among these
concepts (on which work has begun) will result in the
creation of a large number of more complex concepts
defined in terms of these explicitly annotated concepts
in the vein of anonymous OWL classes formally defined
in terms of primitive (or even other anonymous) classes
[61]. Analogous to research done in calculating the in-
formation content of GO terms by analyzing their use in
annotations of genes/gene products in model-organism
databases (and from this, the information content of
these annotations) [62,63], the information content of
biomedical concepts can be calculated by analyzing their
use in annotations of textual mentions in biomedical
documents (and from this, the information content of
these documents).
A crucial difference between the CRAFT Corpus and
many other gold-standard annotated biomedical corpora
is that markup of concepts requires semantic identity.
By this we mean that every annotation in CRAFT is
tagged with a term from an ontology or controlled vo-
cabulary such that the text selected for the annotation is
essentially semantically equivalent to the term; that is,
each piece of annotated text, in its context, has the same
meaning as the formal concept used to annotate it. In
many other corpora, text is marked up even if the con-
cept denoted is more specific than the concept used to
annotate it; this approach is sometimes referred to as
marking up all mentions “within the domain of” the
given annotation class. For example, given a schema
with a cell class (but nothing more specific), most cor-
pora would annotate a mention of the word “erythro-
cyte” to that class. This results in semantic loss: It is not
the case that the annotated text means the same thing
as the associated semantic class. The size of the
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tity make assertions involving annotated concepts more
valuable. For example, if the goal is to identify specific
proteins expressed in specific cell types, annotations to
generic categories such as “protein” or “cell” are not
adequate.
Though it may sound straightforward to mark up all
mentions of a given annotation class, it is often difficult
and can seem subjective. Tateisi et al. have reported on
the difficulty of distinguishing the names of substances
from general descriptions of the substances in the con-
struction of GENIA [64], and there was relatively low
agreement on what qualified as, e.g., activators, repres-
sors, and transcription factors in the GREC [50]. This is
even more difficult when it involves identifying precise
text spans for annotation. Our annotators found that
evaluating whether a span of text is semantically equiva-
lent to a given term is easier than attempting to evaluate
whether a piece of text refers to a concept that is sub-
sumed by a more general schema class but not explicitly
represented. It is for this reason that we emphasize an-
notation to an ontology/terminology rather than to a do-
main. Domain boundaries are often ill-defined, which
makes it difficult to evaluate whether a piece of text
refers to a concept that “should be” in some ontology;
thus, we annotate only to what actually is in an ontology,
not to some abstract idea of its domain. For example, if
the ontology being used to annotate the corpus contains
a concept representing vesicles but nothing more spe-
cific than this, a textual mention of “microvesicle” would
not be annotated, even though it is a type of vesicle; this
is because this mention refers to a concept more specific
than the vesicle concept (and our annotation guidelines
do not allow annotations to a part of a word such as
this). In other cases, a portion of a mention to a concept
missing from an ontology can be marked up; for ex-
ample, for the text “mutant vesicles”, “vesicles” by itself
is tagged with the vesicle concept. We regard such an
approach as a strength, as only text that directly corre-
sponds to concepts represented in the terminology is
selected. Although experts might use such texts to make
suggestions of new concepts to ontology curators, such
activity was in general beyond the scope of the annota-
tion work itself. However, we expect that the CRAFT
Corpus could be exploited by ontology curators to find
such missing concepts.
The CRAFT Corpus is distinguished by the quality
and applicability of the schemas (i.e., potential target
concepts) used for annotation. Many other corpora rely
on concept schemas custom-made for their specific pro-
jects, often with representational idiosyncrasies; such
schemas are not widely reusable for other purposes.
Some corpora, such as the GREC and the event subset
of GENIA, use schemas based, at least in part, onsubsets of established external resources. The CRAFT
Corpus is unique in that it relies on well-established, in-
dependently curated resources in their entirety. Eight of
these resources are formal biomedical ontologies devel-
oped within the sphere of the Open Biomedical Ontolo-
gies (OBO) movement and are dedicated to faithfully
representing the concepts within their respective
domains, including five in the OBO Foundry that con-
form to an additional set of ontological principles. By
predominantly annotating to widely used, high-quality
terminologies, the CRAFT Corpus builds on years of
careful knowledge representation work and is semantic-
ally consistent with a wide variety of other efforts that
exploit these community resources.
In addition to using community-curated resources in
our scheme, CRAFT also annotates every mention of
nearlyc every concept that appears in the texts. Although
such an approach seems intuitive (and is clearly benefi-
cial for training machine-learning NLP systems), it is not
used in a number of corpora. Tanabe et al. have written
that “one fundamental problem in corpus annotation is
the definition of what constitutes an entity to be tagged”
and cited the complex guidelines of the MUC-7 Named
Entity Task as evidence [47]. In BioInfer, the focus is the
annotation of relationships among genes, proteins, and
RNAs, and entities are only annotated if they are rele-
vant to this focus and if they are named entities—a term
itself with much baggage, however, if the arguments of
primary events are other events or qualities that recur-
sively have genes, proteins and/or RNAs as arguments,
these secondary events or qualities are annotated as
“extended named entities”, but they are annotated only
in such cases. In the PennBioIE Oncology corpus, a gene
is only annotated if there is an associated variation
event, and in the i2b2/VA Challenge corpus, only con-
cepts lexicalized as complete noun phrases are anno-
tated; e.g., “diabetes” is annotated in “she developed
diabetes” but not in “she takes diabetes medication”.
The span selection guidelines for the concept annota-
tions of the CRAFT Corpus also provide important
advantages. Given an initial anchor word as the basis for
an annotation, the rules for deciding which adjacent
words can be considered for inclusion in an annotation
and which cannot are precise and purely syntax-based,
and the decision as to whether to include one or more
modifiers or modifying phrases rests solely on whether
their inclusion would result in a direct semantic match
to a concept in the terminology being used. Unlike some
other corpora (e.g., GENETAG, the ITI TXM corpora),
annotations in CRAFT can be discontinuous, i.e., can be
composed of two or more nonadjacent spans of text,
though these must still abide by the same span-selection
guidelines. Use of discontinuous annotations allows us
to ensure that only text that is semantically identical to a
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In some corpora, there are unclear guidelines (and con-
sequently inconsistent annotations) for the text spans
associated with an annotation. For example, in GENIA,
“the inclusion of qualifiers is left to the experts [sic]
judgment” for the task of entity annotation [48], and in
the i2b2/VA Challenge corpus, “[u]p to one prepos-
itional phrase following a markable concept can be
included if the phrase does not contain a markable con-
cept and either indicates an organ/body part or can be
rearranged to eliminate the phrase” [46]. The CRAFT
specifications minimize subjective selections, and in-
crease interannotator agreement on spans. CRAFT text
span-selection guidelines are quite extensive (see supple-
mentary materials), but our biomedical-domain-expert
concept annotators with no previous experience with
formal linguistics were able to quickly learn them.
Finally, few corpora have attempted to capture seman-
tic ambiguity in concept annotations. The most promin-
ent way in which CRAFT represents concept ambiguity
is in cases in which a given span of text could be refer-
ring to two (or more) represented concepts, none of
which subsumes another, and we have not been able to
definitively decide among these. This occurs most fre-
quently among the Entrez Gene annotations, in which
many mentions of genes/gene products not grammat-
ically modified with their organismal sources are multi-
ply annotated with the Entrez Gene IDs of the species-
specific genes/gene products to which these mentions
could plausibly refer. Similar to GENIA, this multiple-
concept annotation explicitly indicates that these cases
could not be reliably disambiguated by human annota-
tors and therefore are likely to be particularly difficult
for computational systems. Explicitly representing this
ambiguity allows for more sophisticated scoring mechan-
isms in the evaluation of automatic concept annotation;
for example, a maximum score could be given if a system
assigned both insertion concepts to the aforementioned
example and a partial score for an assignment of only one
of these concepts. . However, we have attempted to avoid
such multiple annotation by instead singly annotating
such mentions according to improvised guidelines for spe-
cific markup issues (which do not conflict with the official
span-selection guidelines but rather build from them). For
example, some nominalizations (e.g., insertion) may refer
either to a process (e.g., the process of insertion of a
macromolecular sequence into another) or to the resulting
entity (e.g., the resulting inserted sequence), both of which
are represented in the SO, and it is often not possible to
distinguish among these with certainty; we have annotated
such mentions as the resulting sequences except those
that can only (or most likely) be referring to the corre-
sponding processes. A simpler case involves a text span
that might refer to a concept or to another concept that itsubsumes. In such a case, only the more general concept
is used; for example, Mus refers both to a organismal-
taxonomic genus and to one of its subgenera, so a given
mention would only be annotated with the genus; the ra-
tionale for this decision is that it is generally not safe to
assume that the more specific concept is the one being
mentioned.
Ongoing and future work
In addition to the conceptual annotation that is
described here and the syntactic annotation that we de-
scribe in a companion article [27], there are multiple on-
going projects that add additional layers of annotation to
the CRAFT Corpus data, all of which will be made avail-
able in future releases of the corpus:
 We have begun work on assertional annotation of
the corpus, i.e., the markup of assertions among the
annotated concepts by linking them via relations.
We have encountered many difficult aspects in this
task, which may be challenging to accomplish as
consistently as the concept annotation. We seek to
create this assertional markup using a methodology
such that the annotations will be able to be
programmatically translated into formal knowledge
representations that can be stored and queried in an
RDF knowledge base [61].
 An extensive project is nearly complete to mark all
coreference in the corpus. The two relations of
COREF (coreferentiality) and APPOS (appositive) are
marked. The guidelines for this portion of the work
were adapted from the OntoNotes guidelines, with
the major difference that we did not utilize the
category of generics. As we have discussed in relation
to the guideline selection process for this task [28], we
maintain that in the biomedical domain, in which
everything mentioned, including abstract concepts
such as data, belongs in the domain of an ontology,
the notion of genericity does not apply.
 Discourse annotation on the sentence level, using
the CISP/ART schema [65], is nearly complete. An
early result of this work has been the finding that
sequences of rhetorical moves can be characterized
by finite state machines.
 The contents of all parentheses are being annotated
with respect to a schema of twenty categories,
including citations, data values, p-values, figure/table
pointers, list elements, and others. We have
previously presented the annotation procedure and
the use cases for the various categories in the schema,
as well as a classifier for determining category
membership of contents of parentheses [66].
 As a primary criterion in the selection of articles for
the corpus was their use as evidential sources for
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products in the Mouse Genome Database (a major
component of the Mouse Genome Informatics
resources), we have marked up the specific
sentences within these articles upon which these
annotations are based. Motivated by a growing need
for semiautomatic assistance in the curation of data
in model-organism databases, we intend for this to
serve as a gold standard for the training of systems
to identify relevant evidential sentences in the
biomedical literature.
Furthermore, in the future, we intend to periodically
update the annotations using current versions of the
OBOs as well as correct errors that we find or are
brought to our attention.
Conclusions
The concept annotation of the CRAFT Corpus, a collec-
tion of 97 full-length, open-access biomedical journal
articles, is designed to serve as a high-quality gold stand-
ard for the training and testing of advanced biomedical
NLP systems. In our corpus, we have created annota-
tions for all mentions of nearly all concepts from nine
prominent biomedical ontologies and terminologies,
consistently created based on one set of guidelines.
CRAFT displays consistently high interannotator agree-
ment, as evaluated by single-blind review by the lead se-
mantic annotator of the primary annotators’ markup.
At approximately 560,000 tokens in the initial 67-
article release and 830,000 tokens in the full set, the
CRAFT Corpus is among the largest gold-standard
annotated biomedical corpora, and unlike most others,
the journal articles that comprise the documents of the
corpus cover a wide range of biomedical disciplines.
Additionally, with a total concept annotation count of
nearly 100,000 in the initially released 67-article subset
and of over 140,000 in the full collection, the scale of
our conceptual markup is also among the largest of all
comparable corpora. Along with the syntactic and co-
referential annotations that have been created for the
same set of journal articles, the concept annotations of
the CRAFT Corpus have the potential to significantly
advance biomedical text mining by providing a high-
quality gold standard for NLP systems.
Methods
Corpus assembly
The 97 articles of the corpus were selected based on (a)
their use by the Mouse Genome Informatics (MGI) group
[67], each of which was used as an evidential source for
one or more annotations of mouse genes or gene products
in the Mouse Genome Database (MGD) [68] to one
or more terms from the GO and/or the MammalianPhenotype Ontology (MP) [69], and (b) for their unrestric-
tive licensing terms, i.e., available in PubMed Central in
the form of Open Access XML. Table 4 shows counts for
each category; for example, 7,263 articles were used as the
evidential sources for MGI annotations using only GO
terms; of these, 1,249 were available in PubMed Central,
and of these, only 27 were available in PubMed Central in
the form of Open Access XML. Note that although the
last column adds up to 98, one of these articles was not
available in its full-text form at the time the corpus was
being assembled and was thus excluded from it. The 67
articles of the initial release set were selected on the basis
of their being representative of the entire corpus in terms
of distribution of concept annotations. One-way ANOVA
statistics were calculated for each terminology used to an-
notate the corpus, and based on these tests, the release
and test sets were shown to not be statistically different in
terms of these concept-annotation distributions [27].
Ontology/terminology selection
The annotation of the biological concepts in the corpus
was performed using ontologies and other controlled
terminologies in their entirety. These ontologies and ter-
minologies were chosen based on their quality and their
representation of domain-specific concepts frequently
mentioned in biomedical text. As precedence was given
for a representation in the form of a well-constructed,
community-driven ontology, seven of these (ChEBI,
PRO, GO BP, GO CC, GO MF, CL, and SO) are Open
Biomedical Ontologies, and the first five of these are
OBO Foundry ontologies, indicating an official endorse-
ment of quality by this consortium [7]. In addition, to
mark up some essential biological concepts not yet
represented in a proper ontology, we chose to use the
unique identifiers of the NCBI Taxonomy, as this is the
most widely used Linnaean hierarchy of biological taxa,
and the unique identifiers of the Entrez Gene database,
as this is the most prominent resource for information
pertaining to species-specific genes. Details of versions
of all of the ontologies and terminologies used as well as
their application toward the creation of the concept
annotations are presented in the Methodology.
For each annotation pass with an OBO, a version of
the ontology at the start date of the annotation pass was
frozen so that all of the annotations of a given pass were
semantically consistent and relied upon a single ontology
version. Though these ontologies have evolved since the
start of the project, all of the annotations are stored in
terms of their formal IDs, permitting their mapping to
concepts in current versions. We have included the ver-
sions of the ontologies that were used for annotation in
the release package, and we recommend that users rely
on these versions when working with the CRAFT
Corpus.
Table 4 Statistics for MGI annotations and articles
Ontology/Ontologies
Used in Annotation
# Articles Cited as
Evidential Sources
# Articles Cited as Evidential Sources
& Available in PubMed Central
# Articles Cited as Evidential Sources & Available in
PubMed Central as Open Access XML
GO (only) 7,263 1,249 27
MP (only) 10,469 2,699 66
GO & MP 2,174 633 5
Statistics for MGI annotations and articles for the assembly of the CRAFT Corpus.
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Concept-annotation guidelines were created by the se-
mantic annotation lead (MB), a researcher with extensive
experience with biomedical ontologies and knowledge en-
gineering, along with an experienced computational lin-
guist (ME). Initial guidelines were developed through
iterative attempts by MB to manually annotate biomedical
journal articles and assess whether the proper use of the
guidelines consistently resulted in intuitive concept anno-
tations using the terms of the ontology or terminology
with subjective decisions kept to a minimum, revising the
guidelines accordingly. As presented in the Discussion
section, a number of other biomedical concept-annotation
projects suffer from a lack of clarity in terms of selection
of text spans for the annotations, resulting in increased
difficulty of the task and thus decreased performance. To
preclude this, it was decided early in the project that
span-selection guidelines based strictly on syntax would
minimize subjectivity and maximize performance of this
task. This required us to develop an extensive set of
syntax-directed guidelines covering nouns and noun
phrases, adjectives and adjectival phrases, prepositional
phrases, relative clauses, appositions, and adverbs, as well
as rules for overlapping and nesting of concept annota-
tions, coordinated phrases, and discontinuous annota-
tions. Further minimizing subjectivity in the task, we
specified that any such text that is considered for inclusion
in a given annotation is included only if its inclusion
results in a direct semantic match to a concept in the
ontology or terminology being used to annotate the text.
Despite the initial worry that the primary annotators
for this task, all of whom had degrees in the biological
sciences and no formal experience with linguistics,
would have difficulty adhering to the annotation guide-
lines with their detailed basis in syntax, they quickly
achieved proficiency in correct span selection. As they
proceeded to annotate the articles, only minor revisions
had to be made to the syntactic aspects of the guidelines,
and span-selection errors due to nonadherence to these
syntactic aspects accounted for a small minority of the
errors detected in the regular review of their markup by
the semantic lead annotator.
Rather than these syntactic aspects of the guidelines, it
was progressively shown that annotation discrepancy be-
tween the primary annotators and the reviewing semanticlead annotator was mostly the result of semantic issues in
using the ontologies and terminologies for text annota-
tion. These semantic issues can be broken down into two
main subtypes: (1) A part of the ontology or terminology
being used was insufficiently rigorous in its representation
or ill-suited for the task of text annotation, resulting in its
inconsistent use; and (2) The primary annotator was not
aware of some representational aspect of the ontology or
terminology being used. It was these types of semantic
issues that required more substantial amounts of time to
resolve and for which having a knowledge engineer
experienced with these ontologies and terminologies
proved extremely valuable.
Upon encountering an instance of the first semantic
issue subtype through the review of the primary annota-
tors’ markup, the semantic lead annotator, after review-
ing as many annotation instances of the specific issue as
could be found, developed informal (and sometimes sub-
optimal) guidelines for addressing it; this included nar-
rowing the cases in which a set of concepts was to be
used and, in rare circumstances, not using a set of con-
cepts at all. These more informal annotation guidelines,
specific to these issues, were communicated in the peri-
odic meetings with the primary annotators as they arose,
subsequent to which the annotators attempted to follow
them. Multiple rounds of this process, with discussions
among the primary and lead semantic annotators, were
often required until a satisfactory solution with relatively
few discrepancies among the annotators was reached.
Upon encountering an instance of the second semantic
issue subtype, the semantic lead annotator reviewed the
relevant portion or representational aspect of the ontol-
ogy or terminology and its correct use with the primary
annotator in one of their periodic meetings, along with
similar followup to ensure that the latter was subse-
quently using these concepts correctly.
Due to space restrictions, we include a discussion of
our concept-annotation guidelines, which were used for
all nine terminological annotation passes, as supplemen-
tary material to this paper; alternately, the reader may
refer to our previously published paper presenting the
guidelines [70] or to the guidelines in their entirety on
the project Web site (Additional file 2: Doc2). They are
freely available for external use under a Creative Com-
mons license.
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The annotation of the articles with each ontology and
terminology was performed independently with the ex-
ception of the GO BP and MF ontologies, which were
used to mark up the text concurrently in one pass. With
few exceptions, every mention in the articles of the cor-
pus of every concept of the ontologies and terminologies
has been annotated with the appropriate concept(s), and
the guidelines presented as supplementary material were
used for all of the concept-annotation passes. In an at-
tempt to reduce the workload of the human annotators,
most of the annotation passes using an OBO relied on
an initial preprocessing to programmatically create an
initial set of annotations of concept mentions appearing
as exact matches or plurals of names or exact synonyms
of the terms of the OBO.
There was no prior training on other texts; after a
short introduction to the guidelines and to the annota-
tion tool, the annotators began their work directly on
the articles of the corpus. For each of the nine concep-
tual passes, the corpus with its corresponding program-
matically created annotations was then reviewed by a
primary human annotator. All of this primary manual
markup was performed by three annotators, each of
whom has a Ph.D. in the biological sciences, and the an-
notator for the GO BP & MF passes also served as the
primary annotator of GO annotations of mouse genes
and gene products for the MGD. Entailed within this re-
view was the checking of each of the preliminary anno-
tations in terms of its span (i.e., the set of characters
selected) and its class (i.e., the term with which this set
of characters is annotated), making revisions to either or
both of these or deleting the entire annotation as
assessed. Furthermore, the annotator examined the en-
tire text of each article, creating annotations missed by
the programmatic pass. These annotators searched for
concepts among the ChEBI, CL, GO BP/CC/MF, PRO,
and SO ontologies directly in the Protégé-Frames inter-
face, as each of these ontologies was imported into the
corresponding annotation project, while search for con-
cepts in the Entrez Gene and NCBI Taxonomy databases
was performed via their Web interfaces. In each case, the
annotator searched for concepts using their entire names,
synonyms, and then subsets of these, as progressively
required. The Protégé-Frames, Entrez Gene, and NCBI
Taxonomy interfaces all allow for searching for subsets of
concept names, and all return partial matches of inputted
query phrases; searching for existing concepts among the
ontologies and terminologies was not a significant
difficulty.
On an approximately weekly basis, all of these result-
ing annotations were sent to the semantic lead annota-
tor, who subsequently checked each annotation from the
most recent set of annotations in terms of its span andclass, noting any disagreement with the primary manual
markup, and also read through the text to find any pos-
sibly missing annotations. For each of these annotation
sets, a meeting by telephone was conducted between the
primary and semantic-lead annotators, and any annota-
tion disagreements between the primary and the seman-
tic lead annotators were discussed until a consensus was
reached, which sometimes resulted in further changes in
guidelines; the markup was appropriately modified to re-
flect this consensus. IAA statistics were calculated for
each annotation time period.
Knowtator [37], which is implemented as a tab plugin to
Protégé-Frames [71], was used for all semantic-annotation
work. Initial training sessions were conducted face to face
(with the exception of the GO BP & MF annotator, who
was not situated in the local area) until the annotator
gained a reasonable facility with the tool and task. Each
annotator sent his or her Protégé project (which contains
all of the annotations) to the semantic lead on an approxi-
mately weekly basis, and, following the initial training
period, an annotation meeting was conducted individually
by phone after the lead reviewed his or her most recent
markup through the Protégé project. All IAA statistics
were calculated through Knowtator.
Cell type ontology (CL)
For the annotation of cells, we used the 1.26 version of
the CL dating to 2007 05 25, which contains 838 terms.
The CL has a cell line cell term (CL:0000010) but no
specific types of cell-line cells, so these specific types are
not annotated in the corpus. (The Cell Line Ontology
[72] would be useful for this task as future work on the
corpus.)
Chemical entities of biological interest ontology (ChEBI)
The annotation of the corpus with ChEBI relied upon
release version 45, dating to 2008 05 28, which contains
19,633 terms representing types of biochemical roles
and applications, subatomic particles, atoms, molecules
and other polyatomic entities, and their parts (i.e.,
groups). Mentions of elements without specification of
charge have been annotated with terms from the branch
of atoms, while those with specification of charge have
been annotated with terms from the branch of elemental
molecular entities; though these branches are not inte-
grated with each other (as we believe they should), this
protocol allows for the closest semantic matches. Men-
tions of polyatomic ions without specification of charge
are multiply annotated if there is no corresponding
charge-independent ChEBI concept; e.g., “glutamate” is
doubly annotated with glutamate(1-) (CHEBI:14321) and
glutamate(2-) (CHEBI:29987), as there is no more gen-
eral term for glutamate without specification of charge.
There are a number of ChEBI concepts representing
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forms that were challenging to use because many textual
sequence mentions are ambiguous as to whether they
refer to full molecules or to proper subsequences, specif-
ically deoxyribonucleic acids (CHEBI:16991), ribonucleic
acids (CHEBI:33697), oligonucleotides (CHEBI:7754),
dinucleotides (CHEBI:47885), peptides (CHEBI:16670),
oligopeptides (CHEBI:25676), dipeptides (CHEBI:46761),
tripeptides (CHEBI:47923), tetrapeptides (CHEBI:48030),
and pentapeptides (CHEBI:48545). Since this ambiguity
is captured in our annotation of these mentions with
cognate concepts in the sequence ontology, these more
specific ChEBI concepts were not annotated. Annotating
nested parts of mentioned polyatomic entities has been
challenging, as they often can plausibly refer to multiple
concepts; e.g., “amino” of “amino acid” could refer to
amine or amino group, which are both represented in
the ontology (and in different branches); though we have
annotated all such nested ChEBI concepts, we recom-
mend not attempting to mark up ChEBI concepts nested
within other ChEBI concepts when annotating biomed-
ical text, as this would render many of these moot. Fi-
nally, text was not marked up with label (CHEBI:35209)
or tracer (CHEBI:35204), as these concepts were found
difficult to use in practice.
Entrez gene (EG)
The identification of genes and gene products in text
has been a primary focus of biomedical text mining, and
the difficulties encountered in marking up mentions of
these entities (e.g., [45,73]) broadly fall into two categor-
ies: ambiguity of species/taxon and ambiguity of se-
quence type. As for the former, one of the most difficult
aspects of markup up mentions of genes and their
derived sequences has been determining whether a given
mention referred to a species-specific entity, an entity
corresponding to a higher-level biological taxon (e.g.,
mammalian CLN2), or to a taxon-independent entity.
Since all of the entries of the Entrez Gene database are
species-specific, only the mentions of the first type can
be annotated with Entrez Gene entries at all. Unfortu-
nately, it is often not possible to reliably choose among
these options; authors themselves seem to conflate these
types and/or jump from one framing to another, and
more than one of these options often fits for a given
mention. The CRAFT Corpus employs a fairly liberal ap-
proach by marking up a given sequence mention with a
given Entrez Gene ID if it is plausible—not certain—that
the authors are referring to the species-specific sequence
denoted by the ID; in addition, the identity of the species
of the given sequence must be mentioned in the article
itself. With these criteria, the large majority of mentions
of genes and their derived sequences could be annotated
with Entrez Gene IDs. Many of these are annotated withmultiple IDs; this indicates, for a given mention, that the
authors may be referring to any of multiple organisms
mentioned in the article. Mentions of genes and their
derived sequences that are not marked up with Entrez
Gene IDs include (a) those that are found in general/
background statements; (b) those whose organismal
source is not mentioned in the respective journal article,
including those with citations in which the source can
only be determined by examining the cited publication
(s); and (c) those that do not have corresponding Entrez
Gene entries, particularly genes and gene products used
in experiments that are not the focus of the articles' re-
search (e.g., restriction enzymes).
The other primary vexing aspect of this task is the de-
termination of sequence type, an issue that also has been
encountered in other markup efforts. The difficulty in
specifying whether a given mentioned sequence refers to
a gene, a transcript, or a polypeptide is well-known, but
we have also found mentions of sequences denoted by
Entrez Gene records that actually refer to homomeric
complexes, promoters, enhancers, pseudogenes, cDNAs
and quantitative trait loci, among others. In addition to
the aforementioned specification of Entrez Gene IDs, we
initially marked up these mentions with regard to se-
quence type as well, using ontological terms, principally
from the SO, e.g., gene (SO:0000704). However, this task
grew increasingly problematic, and we decided to mark
up these mentions only with regard to Entrez Gene ID.
Therefore, all such mentions are annotated to a generic
Entrez Gene sequence class, and the Entrez Gene ID is
specified in the has Entrez Gene ID field. Furthermore,
these annotations have been created without regard to
sequence type: Not only are genes annotated, but tran-
scripts, polypeptides, and other types of derived sequences
are equivalently marked up with the Entrez Gene IDs of
their corresponding genes. Thus, an Entrez Gene annota-
tion refers to the DNA sequence denoted by the Entrez
Gene record or to some sequence derived from it.
Even though we have removed the ambiguity with
regard to sequence type, the Entrez Gene annotations
could still prove challenging to use due to the aforemen-
tioned ambiguities of whether to mark up a given men-
tion or to regard it as a more general mention and, if it
is to be marked up, which one or more species-specific
sequence versions to use to mark it up. These were diffi-
cult issues even for us as manual annotators, and we
expect that they would be even more difficult for com-
putational systems. We believe that there are no easy
solutions to marking up these sequence mentions with a
species-specific vocabulary such as the Entrez Gene
database and that a vocabulary that includes taxon-
independent sequences should instead be used for
conceptual annotation of these mentions. We have also
marked up mentions of sequences with the PRO
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quence concepts (on which we relied), and we recom-
mend that researchers use the PRO annotations rather
than the Entrez Gene annotations for identification of
genes and gene products in biomedical text, as we are
more confident of the consistency and utility of the
former than the latter.
Gene ontology biological processes (GO BP)
For the annotation of biological processes, we used the
1.9 revision of the GO dating to 2007 11 28, which con-
tains 14,306 BP terms; these processes span a wide range
of granularities, including those at the level of molecules,
subcellular structures, cells, tissues/organs, and organ-
isms and even extend to multiorganismal processes. This
pass accounts for the large majority of verb-based anno-
tations, and it is the most syntactically complex set of
annotations, including many with prepositional phrases
and adjectives/adjectival phrases as well as many discon-
tinuous annotations. For many of the annotations, a
word is marked up with a biological process given the
context even though the word may be used in a more
general sense in another context, e.g., expression, differ-
entiation, and proliferation. Many vexing semantic issues,
small and large, arose during the course of the project
[31,32]. For example, there are many mentions of develop-
ment/production/generation/synthesis/formation processes;
depending on what is being generated, these may be, e.g.,
biosynthetic processes (for molecules and parts of mole-
cules), cellular component assemblies (for cellular compo-
nents), reproduction (for organisms), or developmental
processes (for anatomical parts)–which are all separate
branches of the ontology. The last of these is further com-
plicated by the fact that there are three prominent subhier-
archies of developmental processes (those for formation,
morphogenesis, and development) that have very specific
definitions that by and large do not conform to the mostly
interchangeable textual use of “develop” and its synonyms.
For mentions of developmental processes, we have used the
appropriate development term if there is such a term for
the anatomical structure mentioned in the selected text, the
appropriate formation term if there is a corresponding for-
mation term (and no development term) for the structure,
a morphogenesis term for any explicit mention of morpho-
genesis (as this concept is unambiguous), and the top-level
BP term developmental process (GO:0032502) if there is no
corresponding term in the ontology for the structure and/
or if the structure is not mentioned within the selected text.
A relatively broad set of words have been considered se-
mantically very close for biological regulation (e.g., "moni-
tor", "govern", "control", "guide"), positive regulation (e.g.,
"promote", "augment", "enhance"), and negative regulation
(e.g., "impair", "repress", "suppress"), so these words (along
with their lexical variants) are annotated relying on theseconcepts in appropriate contexts. However, some were
considered semantically narrower than these (e.g., "activate",
"trigger", and "induce" for positive regulation and "block",
"inhibit", and "inactivate" for negative regulation) and thus
were not annotated relying on these concepts.
Gene ontology cellular components (GO CC)
The annotation of the corpus with terms of the GO CC
ontology relies on the aforementioned version of the GO,
which contains 2,047 CC terms representing subcellular
structures, both intracellular and extracellular. This pass of
the annotation is mostly straightforward. One difficulty
concerns chromosomal part (GO:0044427) in that though a
DNA subsequence (e.g., a gene, a QTL) is a part of a
chromosome, these subsequences are not included in this
ontology under chromosomal parts, but authors do refer to
these subsequences as chromosomal regions; we have
attempted to disambiguate the nature of mentions of
chromosomal regions, but it is somewhat subjective with-
out a specification of the relation between the GO CC con-
cept chromosomal part (GO:0044427) and the SO concept
region (SO:0000001). Additionally, this ontology also con-
tains classes representing macromolecular complexes
(which we have previously argued should not be part of this
ontology) that have proven difficult: Often it is unclear
whether a given mention of a macromolecular entity is a
macromolecular complex (in which case it does refer to the
GO CC concept) or a single macromolecule (in which case
it does not); an example of this are mentions of receptors,
which may be either single proteins or protein complexes,
the former of which do not refer to receptor complex
(GO:0043235). It is often difficult to ascertain whether the
type of mentioned receptor can form a complex and if so, if
it is doing so in a particular context; this is even more am-
biguous if multiple types of receptors are being discussed or
if the types of receptors are not specified. Assuming there is
a GO CC macromolecular-complex term to which a given
mention may refer, a mention is straightforwardly anno-
tated if it is clearly specified as a complex, e.g., “receptor
complexes”. If there is no such clear specification, it is
annotated if the mention is also the name of a protein that
may be in the form of a homomeric complex in its context
(e.g., tubulin complex (GO:0045298) for “tubulin”) except if
there is a corresponding MF term (e.g., receptor activity
(GO:0004872) for “receptor”). If there is such a correspond-
ing MF term, the mention is not annotated with the CC
term, since this ambiguity can be captured using the MF
term and the often-tricky issue as to whether to regard and
annotate such as a mention as a macromolecular complex
can be avoided.
Gene ontology molecular functions (GO MF)
As the annotation of GO molecular functions was per-
formed simultaneously with the GO biological processes
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the GO was used, which contains 7,984 MF terms;
among the functions represented by these terms are
types of binding, transporter activity, molecular trans-
ducer activity, and catalytic activity. We have previously
written of the difficulty of distinguishing among and an-
notating with GO BP and MF concepts in text [31,32],
and these issues have continued to make consistent an-
notation of text with GO MF concepts in particular chal-
lenging. As a suboptimal solution, we have narrowly
annotated the articles of the corpus with the GO MF
terms. The majority of these annotations identify mo-
lecular entities possessing the specified functionalities,
and the text spans of these annotations are additionally
marked up with independent_continuant (snap:Indepen-
dentContinuantd); so, for example, the annotation of
“cation channel” with the GO MF concept cation chan-
nel activity (GO:0005261) and also with snap:Indepen-
dentContinuant has the semantics that this text span
refers to an independent continuant that has cation
channel functionality. The one primary subgraph of the
GO MF ontology whose terms are predominantly anno-
tated as molecule-level processes rather than as molecu-
lar entities possessing functionalities is the binding
(GO:0005488) hierarchy.
NCBI taxonomy (NCBITaxon)
As with the annotations with the unique IDs of the records
of the Entrez Gene database, annotators working with the
NCBI Taxonomy directly used the NCBI Taxonomy inter-
face [75] to search for entries denoting organisms. The diffi-
culties in ontological representation of biological taxa has
been discussed elsewhere [76,77]; for this project, we have
regarded the entries of the NCBI Taxonomy database as
denotations of organisms since its taxonomic relationships
hold for organisms (e.g., a rodent is a kind of mammal) but
possibly not for the taxa themselves. (For example, it is not
clear that the order Rodentia is a kind of the classMamma-
lia.) As with all other projects, the closest semantic match
was used; thus, a mention of "rat" (and not more specific
than this) is marked up with Rattus (NCBITaxon:10114),
which has common names of "rat" and "rats" in the data-
base, even if from context it is known to be, e.g., the com-
mon laboratory rat Rattus norvegicus. The terms of the
other sequences (NCBITaxon:28384) and unclassified
sequences (NCBITaxon:12908) subtrees were not used for
markup, as we felt they were of dubious quality and rele-
vance. Mentions of lexical variants of top-level words such
as "organism" and "individual" are annotated with the root
node of the named taxa, root (NCBITaxon:1). In order to
differentiate mentions of organisms (e.g., "rat") from men-
tions of taxa denoting these organisms (e.g., "Rattus"), the lat-
ter are additionally annotated with the term taxonomic_rank
(NCBITaxon:taxonomic_rank). For mentions of taxa thathave identical lexicalizations (e.g., Xenopus denotes both a
genus and a subgenus), the more general one is used. Finally,
mentions of taxonomic ranks themselves (e.g., class, family,
species) are annotated with the appropriate terms of the tax-
onomic_rank subtree.
Protein ontology (PRO)
The annotation of the corpus with the PRO relied on
the 2011 04 22 version of the ontology. Even though this
ontology focuses on proteins (and to a small extent pro-
tein complexes), the articles of the corpus are marked
up with PRO annotations without regard to sequence
type, as with the Entrez Gene annotations. For example,
all “NT-3” sequence mentions are annotated with
neurotrophin-3 (PR:000011459) whether a given men-
tion refers to a gene, a transcript, a polypeptide, or some
other type of derived sequence; thus, the implied seman-
tics of such an annotation encompasses this range of se-
quence types. Even in a case in which the sequence type
is explicitly stated, the sequence type is not included in
the annotation (also as in the Entrez Gene annotations);
for example, for a mention of “NT-3 mRNA”, “NT-3”
alone is marked up with neurotrophin-3. This use of the
PRO has worked well in conjunction with the use of the
SO (see below), as most of these explicitly stated se-
quence types are captured in SO annotations.
Most of the protein concepts of the PRO are taxon-
independent, an attribute that has greatly simplified the
annotation of these specific sequence mentions as com-
pared to the task of their annotation with the entries of
the Entrez Gene database (see above). In some cases,
these taxon-independent protein concepts are subclassed
with species-specific version; for example, the taxon-
independent delphilin (PR:000008239) is subclassed with
delphilin (mouse) (PR:000025479), defined in terms of
Mus musculus. However, these were seldom used, as
even a given sequence mention that explicitly states a
taxon is typically not explicitly species-specific. For ex-
ample, a mention of “mouse delphilin” would not be
annotated with delphilin (mouse) because the mention
only explicitly states “mouse”, whose closest semantic
match is the genus Mus (in concordance with our NCBI
Taxonomy annotations, see above), whereas delphilin
(mouse) is formally defined in the ontology in terms of
Mus musculus (even though it only specifies “mouse” in
the name). Thus, delphilin (mouse) is too taxonomic-
ally specific for this mention, and only “delphilin” of
“mouse delphilin” would be annotated with the taxon-
independent delphilin. However, a mention of “Mus mus-
culus delphilin” would be annotated with delphilin
(mouse), as this would now be a direct semantic match.
Because of the presence of the taxon-independent pro-
tein concepts in the PRO, we were able to annotate
many of the sequence mentions that we were not able to
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ferring to sequences without regard to taxa, those whose
species identities are only indicated in cited articles or
other resources, and those referring to higher-level taxa.
Furthermore, most of the sequence mentions that are
annotated with multiple Entrez Gene entities due to spe-
cies ambiguity are more straightforwardly annotated
with single taxon-independent PRO concepts. We are
more confident of the consistency and utility of the PRO
annotations than the Entrez Gene annotations, and we
recommend using the former for identification of spe-
cific genes and gene products in text.
It should be noted that the PRO ontology file contains
concepts from other ontologies (including the GO, ChEBI,
and NCBI Taxonomy), which are used for classification
and formal definition of PRO concepts. However, we did
not use any of these concepts from other ontologies in the
PRO annotation pass, as they are not PRO concepts, even
though they appear in the ontology file. Therefore, we rec-
ommend that users ignore these concepts (which have
namespace prefixes other than the PRO prefix “PR”) when
using the PRO ontology file (which is included in the re-
lease package, along with all of the other versions of the
ontologies that were used) to annotate text.
Sequence ontology (SO)
The annotation with the SO used the 1.45 revision of the
ontology, dating to 2009 03 30, which contains 1,610 terms
representing types of biomacromolecular sequences, their
attributes, and processes of sequence variation. This set of
annotations is very large considering the relatively small size
of the ontology; this can be accounted for by the very large
number of mentions of basic sequence types such as genes,
proteins, alleles, chromosomes, and genomes in these arti-
cles, all of which are annotated with SO concepts.
This is the only ontology used in this project that con-
tains represented attributes, e.g., flanked (SO:0000357)
and linear (SO:0000987). While some of these have been
straightforward to use and mainly applied to adjectives,
others have not, which necessitated strategies other than
attempting the often-difficult task of classifying a given
mention as a reference to a sequence attribute or to a
sequence itself. Other than flanked, sequence-attribute
concepts lexicalized as past participles, particularly those
classified under gene_attribute (SO:0000401) (e.g., regu-
lated (SO:0000119)) and transcript_attribute (SO:0000237)
(e.g., polyadenylated (SO:0000246)) were not used, as such
mentions were already being annotated as references to
corresponding GO biological processes (see above). The
attributes enzymatic (SO:0001185), peptidyl (SO:0001407),
nucleic_acid (SO:0000348), and all of its subclasses were
treated as independent entities rather than properties, and
so all mentions of these in text, modifying or not, are anno-
tated; for example, all mentions of “peptide” are annotatedwith peptidyl whether they modify other sequence words or
not. The concept transgenic (SO:0000781) was not used at
all, instead annotating all transgene mentions, modifying or
not, with the corresponding independent entity transgene
(SO:0000902).
If not modifying sequences or biological entities contain-
ing sequences, textual mentions annotated with wild_type
(SO:0000817) are also annotated with independent_conti-
nuant (see annotation with GO MF, above) to indicate that
this refers to some unmentioned type of entity with some
specified wild-type sequence. For example, for “as seen in
the wild-type”, where “wild-type” refers to organisms with
some specified wild-type sequence, “wild-type” would also
be annotated with independent_continuant. Similarly,
where “transgenic” indicates unmentioned organisms, it is
annotated with both transgene and independent_conti-
nuant; the same applies to sequence_alteration where, e.g.,
unmentioned mutant organisms are being referenced.
However, users may want to ignore these independent_con-
tinuant annotations and not attempt to distinguish these
cases, as this is a tricky ontological issue.
This version of the SO contains basic types of sequence
variations and their corresponding processes (e.g., substitu-
tion (SO:1000002) and substitute (SO:0000048)) that are
often challenging to differentiate as nominalizations in text.
We have decided to annotate such a nominalization as the
former except where it is reasonably clear that it is referring
to the process, particularly when the nominalization is not
preceded by an article, e.g., “by substitution”. Finally, the
concepts of the sequence_variant_effect (SO:1000132) and
chromosome_variation (SO:0000240) subgraphs of the SO
were not used, as their representation and definition were
problematic, which hindered their use toward annotation.
However, we have begun collaborative work with the devel-
opers of the SO toward an improved representation of se-
quence variation [78], along with other representational
refinements [79].
Endnotes
aThroughout this paper, we have written of our seman-
tic annotation in terms of concepts, which refer to the
classes/terms of the ontologies and terminologies being
used. We are aware of published work that emphasizes
that ontologies and terminologies represent reality rather
than concepts [29,30], and for those readers who sub-
scribe to this view, the word “concept” may be substi-
tuted with “class”, “universal”, or “type” throughout.
Also, we note that what we call concepts are sometimes
referred to in the NLP literature as “named entities”;
however, since not all of the: entries in all of source
ontologies are universally agreed to be “entities” (cf. pro-
cesses), we again prefer the term “concept”.
bAmong the challenges of using the BP and MF sub-
ontologies are their many cognate terms, as for many
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the appropriate subontology to draw from. Despite this
and other challenging aspects, the annotators achieved
an IAA of ~80% by the end of the project. This ambigu-
ity is challenging for other uses of the GO as well, and
we are still in contact with GO curators with regard to
clarification and more consistent application of GO
terms. As the semantic distinction between cognate
process and function terms is practically often modest,
the reported IAA is probably adequate for most uses.
cA small number of concepts from the terminologies
were not used due to ambiguity and/or insufficiently
clear definition. Details in the Methods section.
dThe Open Biomedical Ontology consortium has
agreed to use the Basic Formal Ontology (BFO) [74] as
the upper-level ontology with which the domain-specific
OBOs will be integrated, and in the BFO, an independ-
ent continuant, which encompasses most straightfor-
ward entities such as molecules, is essentially an entity
that does not depend on another entity for its existence.
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